0001333822false00013338222024-07-082024-07-08

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): July 8, 2024

SEMILEDS CORPORATION

(Exact name of registrant as specified in charter)

 

Delaware

001-34992

20-2735523

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

3F, No.11 Ke Jung Rd., Chu-Nan Site,

Hsinchu Science Park, Chu-Nan 350,

Miao-Li County, Taiwan, R.O.C.

 

350

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: +886-37-586788

N/A

(Former name or former address if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0000056

LEDS

The Nasdaq Stock Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

1


Item 1.01 Entry into a Material Definitive Agreement.

On January 8, 2019, SemiLEDs Corporation (the “Company”) entered into a secured loan agreement with Trung Doan, its Chairman and Chief Executive Officer, with an aggregate amount of $1.7 million and an annual interest rate of 8% (the “Loan Agreement”). The Loan Agreement is secured by a second priority security interest on the Company’s headquarters building. The maturity date of the Loan Agreement was January 14, 2021. On January 16, 2021, the maturity date of the Loan Agreement was extended with same terms and interest rate for one year to January 15, 2022, and on January 14, 2022, the maturity date of the Loan Agreement was extended again with same terms and interest rate for one more year to January 15, 2023. On January 13, 2023, the maturity date of the Loan Agreement was further extended with same terms and interest rate for one year to January 15, 2024. On January 7, 2024, the Company amended the Loan Agreement to extend the maturity date to January 15, 2025. On February 9, 2024, the Company (i) amended the Loan Agreement to permit the Company to repay up to $800,000 of principal under the Loan Agreement by issuing shares of the Company’s common stock and (ii) elected to prepay $800,000 of loan principal by delivering 629,921 shares of the Company’s common stock to Mr. Doan, based on the closing price of $1.27 per share on February 8, 2024. All other terms and conditions of the Loan Agreement remained the same.

On July 3, 2024, the Company and Trung Doan entered into the Sixth Amendment to the Loan Agreement (the “Sixth Amendment”). The Sixth Amendment amends the Loan Agreement to permit, upon the mutual agreement of the Company and Trung Doan, the Company to repay a portion of the principal amount or accrued interest under the Loan Agreement, by issuing shares of the Company’s common stock to Trung Doan as partial repayment of the Loan Agreement at a price per share equal to the closing price of the Company’s common stock immediately preceding the business day of the payment notice date. All other terms and conditions of the Loan Agreement, as amended by the Sixth Amendment, remain the same.

The foregoing description of the Sixth Amendment to the Loan Agreement is a summary only and is qualified in its entirety by the full text of the Sixth Amendment, a copy of which is attached hereto as Exhibit 10.1 to this Current Report on Form 8-K, and is incorporated by reference herein.

2


Item 2.02. Results of Operations and Financial Condition.

On July 8, 2024, SemiLEDs Corporation issued a press release announcing its preliminary financial results for the third quarter of its fiscal year 2024, ended May 31, 2024.

Such information is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 3, 2024, the Company’s Board of Directors (the “Board”) appointed Dr. Chris Chang Yu as a director of the Company effective immediately, for a term expiring at the next annual meeting of stockholders or until his successor shall have been duly elected and qualified, or his earlier removal or resignation. Dr. Yu has also been appointed to the Audit Committee by the Board.

Dr. Yu, 66, has served as a director since July 2024. Dr. Yu currently serves as the Chairman of the Board of CRS Holding Inc., Changhe Bio-Medical Science Co., Ltd, Ningkasai Science (Shanghai) Co., Ltd, Changwei System Science (Shanghai) Co., Ltd, Anpac Bio-Medical Science (Lishui) Co., Ltd, Adanced Life Therapeutics Co., Ltd and New-Herizon Bio-Medical Science Co., Ltd and as executive director of Anpac Bio-Medical Science (Shanghai) Co., Ltd, Lisui Anpac Medical Laboratory Co., 3Ltd, Shiji (Hainan) Medical Technology Co., Ltd, Shanghai Muqing Anpac Health Technology Co., Ltd, Anpac (Shanghai) Health Management Consulting Co., Ltd and Annadi Life Technology (Zhejiang) Co., Ltd. Dr. Yu also currently serves as a director of Anji Cayman, serves as an executive partner of Jiaxing Changxin Enterprise Management Partnership (Limited Partnership) and Jiaxing Ningbeika Enterprise Management Partnership (Limited Partnership), and serves as a general manager of Changhe Bio-Medical Science Co., Ltd and Annadi Life Technology (Zhejiang) Co., Ltd. Dr. Yu is also a co-founder of Fresh2 Group Limited (formerly named AnPac Bio-Medical Science Co., Ltd.). Dr. Yu served as Chairman of the Board and Chief Executive Officer of Fresh2 Group from its inception in January 2010 until April 2022 and was re-appointed as Co-Chairman of the Board and Co-CEO in May 2022. He subsequently resigned as Co-Chairman of the Board of Fresh2 Group in October 2022 and resigned as Co-CEO in May 2023. Prior to founding Fresh2 Group, he co-founded Anji Microelectronics (Shanghai) Co., Ltd. in 2004. Dr. Yu served as a technical director at Semiconductor Manufacturing International Corporation from 2002 to 2004. Dr. Yu also served as a vice president of the research and development team of Cabot Microelectronics Corporation. Dr. Yu received his bachelor and master’s degrees in physics from the University of Missouri Kansas-City Campus. He received his doctoral degree in physics from the Pennsylvania State University. The Board has determined that Dr. Yu should serve as a director based on his significant experience managing integrated circuit and technology companies and his experience as a CEO and director of a public company.

Dr. Yu has (i) no arrangements or understandings with any other person pursuant to which he was selected as a director, and (ii) no family relationship with any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer. In addition, Dr. Yu (i) has had no direct or indirect material interest in any transaction or series of similar transactions contemplated by Item 404(a) of Regulation S-K, and (ii) as of the date of this Current Report on Form 8-K, holds no direct or indirect beneficial ownership in the Company’s common stock or rights to acquire the Company’s common stock.

The Board has determined that Dr. Yu qualifies as an independent director pursuant to Rule 10A-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules of The Nasdaq Stock Market. With the appointment of Dr. Yu to the Audit Committee, the Company believes its Audit Committee once again meets the requirements of Nasdaq Listing Rule 5605(c)(2)(A), being comprised of three independent members.

With the appointment of Dr. Yu to the Audit Committee, the Company believes its Audit Committee once again meets the requirements of Nasdaq Listing Rule 5605(c)(2)(A), being comprised of three independent members.

In connection with his appointment to the Board, Dr. Yu will receive the standard compensation paid by the Company to all of its non-employee directors and as described under “Director Compensation” in “Part III - Item 11. Executive Compensation” in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2023 filed with the Securities and Exchange Commission (“SEC”) on November 28, 2023. In connection with his appointment, Dr. Yu will enter into a standard indemnification agreement with the Company in the form previously approved by the Board, which is filed as Exhibit 10.11 to the Company’s Registration Statement on Form S-1 filed with the SEC on October 26, 2010.

3


Item 8.01 Other Events.

The Company will hold its 2024 Annual Meeting of Stockholders (the “Annual Meeting”) on August 29, 2024. All other relevant information concerning the Annual Meeting will be included in the Company’s proxy materials to be distributed in connection with the Annual Meeting, which will be filed with the SEC and made available to the Company’s stockholders.

Because the date of the Annual Meeting is more than 30 days prior to the anniversary date of the Company’s Annual Meeting of Shareholders held in 2023, the Company is providing in this Current Report on Form 8-K the due dates for submissions of qualified shareholder proposals and shareholder director nominations.

To be eligible for inclusion in the proxy materials for the Annual Meeting pursuant to Rule 14a-8 of the Exchange Act, stockholder proposals (including any additional information specified in the Bylaws) must be received by our Corporate Secretary at the Company’s principal executive offices no later than July 15, 2024.

A stockholder proposal or director nomination (including nominations pursuant to Rule 14a-19 under the Exchange Act) outside of Rule 14a-8 under the Exchange Act and pursuant to the Bylaws must be received by our Corporate Secretary at the Company’s principal executive offices by July 15, 2024.

Stockholder proposals and stockholder director nominations must comply with all applicable requirements set forth in the rules and regulations of the SEC, the Exchange Act, and the Company’s bylaws.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

 

Description

 

 

 

10.1

 

Sixth Amendment to Loan Agreement dated July 3, 2024 between SemiLEDs Corporation and Trung Doan

  99.1

 

Press release, dated July 8, 2024, entitled “SemiLEDs Reports Third Quarter Fiscal Year 2024 Financial Results.”

104

 

Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document.

 

4


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: July 8, 2024

 

 

 

 

 

 

 

 

 

SemiLEDs Corporation

 

 

 

 

 

 

 

By:

 

/s/ Christopher Lee

 

 

Name:

 

Christopher Lee

 

 

Title:

 

Chief Financial Officer

 

5


 

SIXTH AMENDMENT TO LOAN AGREEMENT

 

This Sixth Amendment to Loan Agreement (this “Sixth Amendment”) is entered into as of July 3, 2024 (“Effective Date”) by and between SemiLEDs Corporation (“Borrower”), and Trung Doan (“Lender”) (the Borrower and the Lender are hereinafter collectively referred to as “Parties”, and individually a “Party”).

 

WHEREAS, the Parties have entered into that certain Loan Agreement as of January 8, 2019 (“Original Agreement”), and the Amendment to the Loan Agreement dated January 16, 2021 (“Amendment”); the Second Amendment to the Loan Agreement dated January 14, 2022 (“Second Amendment”); the Third Amendment to the Loan Agreement dated January 13, 2023 (“Third Amendment”); the Fourth Amendment to the Loan Agreement dated January 7, 2024 (“Fourth Amendment”) and the Fifth Amendment to the Loan Agreement dated February 9, 2024 (“Fifth Amendment”) the Maturity Date thereunder being January 15, 2025. The Loan Agreement together with the Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment and all Loan Documents are hereby collectively referred to as the “Loan Agreement”.

 

NOW, THEREFORE, the Parties desire to document the change of the Loan Agreement as follows:

 

1.
In addition to the terms defined elsewhere in this Sixth Amendment, capitalized terms used in this Sixth Amendment shall have the same meanings ascribed to them in the Loan Agreement.
2.
The Parties agree to amend Section 2.5 of the Loan Agreement from:

“2.5 Repayment Mechanics. All repayments hereunder shall be made by wire transfer of such amounts in immediately available funds denominated in U.S. Dollars (USD) to the Lender, at such place and to such account as the Lender shall designate in a written notice to the Borrower. Payments shall be credited first to costs and expenses due and payable hereunder (including the costs incurred under Sections 8.3), then to the accrued interest then due and payable and the remainder applied to principal. The Loan may be prepaid, without penalty or premium, in whole or in part from time to time, provided that:

(a) Notice: the Borrower shall have given the Lender not less than three (3) Business Days’ (or such shorter period as may be agreed between the Borrower and the Lender) prior written notice specifying the amount to be prepaid and the date of prepayment; and

(b) Interest: the Borrower shall concurrently pay accrued and unpaid interest on the full amount of the Loan to be prepaid on the date of such prepayment.”

to:

“2.5 Repayment Mechanics. All repayments hereunder shall be made by wire transfer of such amounts in immediately available funds denominated in U.S. Dollars (USD) to the Lender, at such place and to such account as the Lender shall designate in a written notice to the Borrower. Payments shall be credited first to costs and expenses due and payable hereunder (including the costs incurred under Sections 8.3), then to the accrued interest then due and payable and the remainder applied to principal. The Loan may be prepaid, without penalty or premium, in whole or in part from time to time, provided that:

(a) Notice: the Borrower shall have given the Lender not less than three (3) Business Days’ (or such shorter period as may be agreed between the Borrower and the Lender) prior written notice specifying the amount to be prepaid and the date of prepayment; and


 

(b) Interest: the Borrower shall concurrently pay accrued and unpaid interest on the full amount of the Loan to be prepaid on the date of such prepayment.

(c) Repayment Mechanics Exception: the Borrower may, upon mutual agreement of the Parties, repay a portion of the principal amount or accrued interest, by issuing the Borrower’s common stock in the name of Lender as partial repayment of the Loan; the price per share of common stock would be the closing price immediately preceding the business day of the payment notice date which could be by email.”

3.
The Parties agree that corresponding changes shall be made to the Note attached to the Loan Agreement as follow:

Section 1 of the Note shall be amended to provide that Borrower may, upon mutual agreement of Borrower and Lender (or the Company and Holder as defined in the Note), repay a portion of the principal amount or accrued interest, by issuing the Borrower’s (or the Company’s as defined in the Note) common stock in the name of the Lender (or the Holder as defined in the Note) as partial repayment of the Note; the price per share of common stock would be the closing price immediately preceding the business day of the payment notice date which could be by email.

4.
Unless otherwise expressly provided herein, all other terms and conditions in the Loan Agreement shall remain in full force and effect.
5.
This Sixth Amendment shall be deemed as an integral part of the Loan Agreement but shall take precedence if there is any discrepancy between this Sixth Amendment and the Loan Agreement.
6.
This Sixth Amendment may be executed, including execution by email, in any number of counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same document.

 

The Parties hereto have caused this Sixth Amendment to be executed and delivered as of the date first written above.

 


 

 

SemiLEDs Corporation

 

By: /s/ Christopher Lee

Name: Christopher Lee

Title: Chief Financial Officer

Trung Doan

 

By: /s/ Trung Doan

Name: Trung Doan

Title: Chairman of the Board


 

Exhibit 99.1

 

img261740701_0.jpg 

 

SemiLEDs Reports Third Quarter Fiscal Year 2024

Financial Results and Engages Financial Advisor

Hsinchu, Taiwan (July 8, 2024)— SemiLEDs Corporation (NASDAQ: LEDS), “SemiLEDs” or the “Company,” a developer and manufacturer of LED chips and LED components, today announced its financial results for the third quarter of fiscal year 2024, ended May 31, 2024.

Revenue for the third quarter of fiscal 2024 increased to $1.3 million, compared to $886 thousand in the second quarter of fiscal 2024. GAAP net loss attributable to SemiLEDs stockholders for the third quarter of fiscal 2024 decreased to $319 thousand, or $(0.06) per diluted share, compared to a net loss of $559 thousand, or $(0.11) per diluted share, in the second quarter of fiscal 2024.

GAAP gross margin for the third quarter of fiscal 2024 increased to 41%, compared to 13% for the second quarter of fiscal 2024. Operating margin for the third quarter of fiscal 2024 was negative 36%, compared with negative 94% for the second quarter of fiscal 2024. The Company’s cash and cash equivalents were $1.7 million at May 31, 2024, compared to $1.6 million at the end of the second quarter of fiscal 2024.

We expect revenue for the fourth quarter ending August 31, 2024 to be approximately $1.0 million +/- 10%.

The Company has engaged Roth Capital Partners, LLC as the Company’s financial advisor to explore potential strategic alternatives.

About SemiLEDs

SemiLEDs develops and manufactures LED chips and LED components for general lighting applications, including street lights and commercial, industrial, system and residential lighting, along with specialty industrial applications such as ultraviolet (UV) curing, medical/cosmetic, counterfeit detection, horticulture, architectural lighting and entertainment lighting. SemiLEDs sells blue, white, green and UV LED chips.

1


 

Forward Looking Statements

This press release contains statements that may constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, revenue expectations for the fourth quarter ending August 31, 2024, the consideration of potential strategic alternatives, any statements about historical results that may suggest trends for SemiLEDs’ business; any statements of the plans, strategies and objectives of management for future operations; any statements of expectation or belief regarding recovery of the LED industry, market opportunities and other future events or technology developments; any statements regarding SemiLEDs’ position to capitalize on any market opportunities; and any statements of assumptions underlying any of the foregoing. There can be no assurance that SemiLEDs will be able to identify or execute upon any strategic alternatives or, if alternatives are identified, the possible terms of any such strategic agreement. These forward-looking statements are based on current expectations, estimates, forecasts and projections of future SemiLEDs’ or industry performance based on management’s judgment, beliefs, current trends and market conditions and involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. SemiLEDs’ Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) and other SemiLEDs filings with the SEC (which you may obtain for free at the SEC’s website at http://www.sec.gov) discuss some of the important risks and other factors that may affect SemiLEDs’ business, results of operations and financial condition. SemiLEDs undertakes no intent or obligation to publicly update or revise any of these forward looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Contacts:

 

Christopher Lee

Chief Financial Officer

SemiLEDs Corporation

+886-37-586788

investor@semileds.com

 

 

 

 

2


 

SEMILEDS CORPORATION AND SUBSIDIARIES

Unaudited Condensed Consolidated Balance Sheets

(In thousands of U.S. dollars)

 

 

 

May 31,

 

 

February 29,

 

 

 

 

2024

 

 

2024

 

 

ASSETS

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,676

 

 

$

1,613

 

 

Restricted cash and cash equivalents

 

 

77

 

 

 

79

 

 

Accounts receivable (including related parties), net

 

 

668

 

 

 

748

 

 

Inventories

 

 

3,673

 

 

 

3,751

 

 

Prepaid expenses and other current assets

 

 

282

 

 

 

245

 

 

Total current assets

 

 

6,376

 

 

 

6,436

 

 

Property, plant and equipment, net

 

 

2,788

 

 

 

2,996

 

 

Operating lease right of use assets

 

 

1,109

 

 

 

1,313

 

 

Intangible assets, net

 

 

91

 

 

 

96

 

 

Investments in unconsolidated entities

 

 

957

 

 

 

986

 

 

Other assets

 

 

190

 

 

 

192

 

 

TOTAL ASSETS

 

$

11,511

 

 

$

12,019

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

Current installments of long-term debt

 

$

2,848

 

 

$

2,859

 

 

Accounts payable

 

 

203

 

 

 

179

 

 

Accrued expenses and other current liabilities

 

 

2,665

 

 

 

2,562

 

 

Other payable to related parties

 

 

952

 

 

 

904

 

 

Operating lease liabilities, current

 

 

108

 

 

 

132

 

 

Total current liabilities

 

 

6,776

 

 

 

6,636

 

 

Long-term debt, excluding current installments

 

 

969

 

 

 

1,110

 

 

Operating lease liabilities, less current portion

 

 

1,001

 

 

 

1,181

 

 

Total liabilities

 

 

8,746

 

 

 

8,927

 

 

Commitments and contingencies

 

 

 

 

 

 

 

EQUITY:

 

 

 

 

 

 

 

SemiLEDs stockholders’ equity

 

 

 

 

 

 

 

Common stock

 

 

 

 

 

 

 

Additional paid-in capital

 

 

187,306

 

 

 

187,275

 

 

Accumulated other comprehensive income

 

 

3,530

 

 

 

3,571

 

 

Accumulated deficit

 

 

(188,121

)

 

 

(187,802

)

 

Total SemiLEDs stockholders' equity

 

 

2,715

 

 

 

3,044

 

 

Noncontrolling interests

 

 

50

 

 

 

48

 

 

Total equity

 

 

2,765

 

 

 

3,092

 

 

TOTAL LIABILITIES AND EQUITY

 

$

11,511

 

 

$

12,019

 

 

 

3


 

SEMILEDS CORPORATION AND SUBSIDIARIES

Unaudited Condensed Consolidated Statements of Operations

(In thousands of U.S. dollars and shares, except per share data)

 

 

 

Three Months Ended

 

 

 

 

May 31,

 

 

February 29,

 

 

 

 

2024

 

 

2024

 

 

Revenues, net

 

$

1,323

 

 

$

886

 

 

Cost of revenues

 

 

780

 

 

 

774

 

 

Gross profit

 

 

543

 

 

 

112

 

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

 

320

 

 

 

251

 

 

Selling, general and administrative

 

 

696

 

 

 

693

 

 

Total operating expenses

 

 

1,016

 

 

 

944

 

 

Loss from operations

 

 

(473

)

 

 

(832

)

 

Other income (expenses):

 

 

 

 

 

 

 

Investment loss from unconsolidated entities

 

 

(3

)

 

 

(5

)

 

Interest expenses, net

 

 

(58

)

 

 

(65

)

 

Other income, net

 

 

277

 

 

 

377

 

 

Foreign currency transaction loss, net

 

 

(59

)

 

 

(32

)

 

Total other income, net

 

 

157

 

 

 

275

 

 

Loss before income taxes

 

 

(316

)

 

 

(557

)

 

Income tax expense

 

 

 

 

 

 

 

Net loss

 

 

(316

)

 

 

(557

)

 

Less: Net income attributable to noncontrolling interests

 

 

3

 

 

 

2

 

 

Net loss attributable to SemiLEDs stockholders

 

$

(319

)

 

$

(559

)

 

Net loss per share attributable to SemiLEDs stockholders:

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.06

)

 

$

(0.11

)

 

Shares used in computing net loss per share attributable to SemiLEDs stockholders:

 

 

 

 

 

 

 

Basic and diluted

 

 

4,914

 

 

 

4,905

 

 

 

4


v3.24.2
Document and Entity Information
Jul. 08, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 08, 2024
Entity Registrant Name SEMILEDS CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-34992
Entity Tax Identification Number 20-2735523
Entity Address, Address Line One 3F, No.11 Ke Jung Rd., Chu-Nan Site
Entity Address, Address Line Two Hsinchu Science Park, Chu-Nan 350
Entity Address, City or Town Miao-Li County
Entity Address, Country TW
Entity Address, Postal Zip Code 350
City Area Code 886
Local Phone Number 37-586788
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001333822
Title of 12(b) Security Common Stock, par value $0.0000056
Trading Symbol LEDS
Security Exchange Name NASDAQ

SemiLEDS (NASDAQ:LEDS)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more SemiLEDS Charts.
SemiLEDS (NASDAQ:LEDS)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more SemiLEDS Charts.